Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 250

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Inhibition of Hypertrophy Is a Good Therapeutic Strategy in Ventricular Pressure Overload

Open access
Schiattarella, Gabriele G., Hill, Joseph A. · 2015 · Circulation

Abstract

H ypertrophic growth of ventricular myocytes is a hallmark feature of numerous forms of cardiovascular disease. 1 The hypertrophic process is complex, involving a vast array of structural, signaling, transcriptional, electrophysiological, metabolic, and functional events within the growing cell.2,3 Other cellular elements within the ventricle, fibroblasts, vascular smooth muscle cells, and endothelium, also manifest intricate stress responses, resulting in fibrosis, inflammatory cell infiltration, endothelial dysfunction, and vascular stiffness.Current thinking holds that these events, the reaction of the heart to a host of pathological stresses, provide short-term benefit.However, if disease-related stress remains unchecked, these remodeling events become maladaptive and predispose to cardiovascular morbidity and mortality. Response by Crozatier and Ventura-Clapier on p 1447Among the risks conferred by disease-related ventricular hypertrophy are ventricular tachyarrhythmia, predisposing to sudden cardiac death, and transition to heart failure.Ultimately, these events derive from wholesale reprogramming and relative dedifferentiation of the cardiac myocyte, coupled with similar events in other cell types.Conventional thinking holds that hypertrophic growth of the myocardium is a compensatory response of the heart to increases in workload demand, serving to minimize wall stress and maintain contractile function.However, several lines of evidence, preclinical and epidemiological, highlight the maladaptive features of chronic ventricular hypertrophy.Indeed, in many instances, suppression of load-induced growth is well tolerated.4 Furthermore, left ventricular hypertrophy is among the most robust markers of increased risk for developing chronic heart failure.5 Therefore, we submit that suppression of load-induced ventricular hypertrophy warrants careful consideration as a therapeutic strategy. Cardiomyocyte Hypertrophy: Comprehensive Reprogramming of the CellAlthough evidence suggests that a small fraction of cells within the ventricle are capable of re-entering the cell cycle, [6][7][8] the majority of cardiomyocytes are postmitotic and, hence, do not retain the ability to divide.Rather, they respond to stress by growing, shrinking, or dying.In the context of many disease-related stresses, cardiac myocytes undergo hypertrophic transformation, which entails significant cellular growth.In the setting of uncontrolled hypertension, for example, cardiomyocytes hypertrophy.Similarly, after myocardial infarction, surviving cardiac myocytes in border and remote zones of tissue increase in size in response to increases in hemodynamic

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.013894

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 250

Metadata

Authors
Schiattarella, G. G., & Hill, J. A.
Venue
Circulation
Published
2015-04-21
Volume
131
Issue
16
Pages
1435-1447
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1998860713
Cited by
250
References
12
FWCI
15.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.